USD 12.11 Billion
Stem Cell Therapy Market Size, Share, Growth Analysis, By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, and Other), By Application (Cancer, Musculoskeletal Disorder, Wounds & Injuries, Cardiovascular Disease), By Type (Allogeneic Transplants, and Autologous Transplants), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2162 |
Region:
Global |
Published Date: August, 2024
Pages:
219
|Tables:
93
|Figures:
76
Stem Cell Therapy Market Insights
Global Stem Cell Therapy Market size was valued at USD 12.11 Billion in 2022 poised to grow from USD 13.33 Billion in 2023 to USD 28.79 Billion by 2031, growing at a CAGR of 10.1% in the forecast period (2024-2031).
Stem cells are the body's source of raw materials, and other cells in the body that have different functions develop from them. Regenerative medicine is also known as stem cell therapy, which is the use of stem cells or cells derived from them to improve the natural healing process of damaged, dysfunctional or diseased tissue in an organism. It is the next stage of organ transplantation, using cells rather than the few donor organs. In a lab, researchers cultivate stem cells. These stem cells are modified to become different kinds of cells, like blood, neurone, or heart muscle cells. The rise of the global stem cell therapy market is also significantly aided by the rising incidence of diseases like cancer and the introduction of new products related to the treatment.
The cells may also be inserted into an individual. The cells might be injected into the heart muscle, for example, if the patient has cardiac problems. After transplantation, the healthy heart muscle cells may help heal the damaged heart muscle. During the stem cell transplant procedure, the donor's immune system fights blood-related disorders and cancers such as leukemia, lymphoma, neuroblastoma, and multiple myeloma, or the damaged cells are replaced with the stem cells by chemotherapy. Umbilical cord blood or adult stem cells are used in these transplants. Stem cell therapy presents market potential due to the increase in induced pluripotent stem cells in embryonic stem cell therapy.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Allogenic
Fastest Growth
Allogenic
Growth Rate
10.1% CAGR
Global Stem Cell Therapy Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Stem Cell Therapy Market Segmental Analysis
The global stem cell therapy market is segmented based on Cell Source, Application and Type. In terms of Cell Source, the market is segmented into Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells and Other. Based on the Application, the market is grouped into Cancer, Musculoskeletal Disorder, Wounds & Injuries, Cardiovascular Disease and Other. Based on the Type, the market is divided into Allogeneic Transplants and Autologous Transplants. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa.
Analysis by Type
As per categorization by type, the stem cell therapy market is classified as allogeneic transplants and autologous transplants. Among these, autologous transplants earned the largest share and continue to dominate the market. The stem cell industry is dominated by autologous transplants, in which patients use their own stem cells for therapy, since they have a lower risk of immunological rejection and consequences than allogeneic transplants. Advances in cell processing and preservation methods have increased their efficacy, which is why customized treatments are best served by using cells.
The global stem cell therapy market is expected to witness rapid growth in the allogeneic transplant segment due to developments in immune suppression tactics and matching technologies. Their growing acceptance and business expansion are driven by their promise to treat more illnesses through donor cells from well individuals.
Analysis by Application
With developments like CAR-T cell therapy and tailored stem cell engineering, stem cell therapy applications for cancer are progressing. These methods can be credited for their market share dominance as they offer customized and sophisticated treatments against a lot of cancers. These have led to increased effectiveness and improved patient outcomes responsible for their growth in the marketplace and widespread use.
A lot is changing in stem cell-based regenerative treatments helping heart function and repair leading to projections that cardiovascular diseases applications will be among the fastest growing in global stem cell therapy market. The rising prevalence of cardiovascular diseases along with innovation in clinical tests has resulted in quick uptake and growth of businesses.
Global Stem Cell Therapy Market By Type (%)
To get detailed analysis on other segments, Request For Free Sample Report
Stem Cell Therapy Market Regional Insights
North America leads the global stem cell therapy market due to its robust regulatory backing, significant investments in research and development as well as an elaborate healthcare network. This region also houses key biotech firms and scholarly bodies which stimulates advancement of stem cell technologies. Furthermore, a strong demand for cutting-edge medicines and the increasing frequency of chronic diseases fuel market expansion. The region's leadership is further strengthened by the financing for stem cell research and the supportive policies of the U.S. government. North America's market dominance is further attributed to the existence of significant market players and a firmly structured clinical trial infrastructure.
Asia Pacific has the fastest growth in the stem cell therapy market due to its rapidly growing health care sector, more government funding and supportive regulatory frameworks. Countries like China, Japan, and South Korea are leading in stem cell research and clinical trials fueled by a growing emphasis on regenerative medicine. The demand for new treatments is stimulated by the region’s large and aging population coupled with rising incidences of chronic diseases. Lower manufacturing and operational costs as well as increased collaborations between academic institutions and biotechnology companies are other reasons why Asia Pacific is experiencing rapid growth and significance in the worldwide market.
Global Stem Cell Therapy Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Stem Cell Therapy Market Dynamics
Global Stem Cell Therapy Market Drivers
More Money Allocated to Stem Cell Research:
- Financial assistance from governmental organizations and appropriate regulatory frameworks promotes a conducive atmosphere for stem cell therapy research and development. Increased research efforts and availability of funding for cell-based studies have generally arisen from the need for better and more creative treatment options for autoimmune, neurological, and cardiovascular diseases.
Emergence of iPSCs as an ESC Substitute:
- The overall cost of clinical trials can be decreased by using iPSCs for various purposes, including the advancement of regenerative medicine and drug discovery (including cytotoxicity studies and disease modelling). The creation of pluripotent cells that match the patient's genetic makeup is made possible by iPSCs in stem cell therapy.
Restraints
Issues of Ethics Pertaining to Embryonic Stem Cells:
- The commercial development of stem cell treatment has been severely hampered by ethical worries regarding embryonic stem cells. Embryonic stem cells are the main concern as they are mostly taken from human embryos which create ethical dilemmas on potential human life elimination. The environment for stem cell research and therapies varies widely due to regulations and opinions.
Technical Limitations:
- It becomes challenging for a manufacturer to scale up the production due to technological challenges encountered at several manufacturing phases, such as stem cell identification, isolation, storage, and preservation. Large-scale stem cell production is anticipated to be hampered by limited manufacturing capacity for production scale-up. The research phase's development process has an impact on the scaling-up process as well.
Request Free Customization of this report to help us to meet your business objectives.
Stem Cell Therapy Market Competitive Landscape
The global stem cell therapy market is extremely competitive worldwide, with major competitors spearheading research and growth. The global firms like Mesoblast Limited, Athersys, Inc., and Novartis AG have strong R&D pipelines and advanced stem cell drugs. They focus on clinical trials, launches of new products or strategic partnerships as a way of maintaining their competitive edge. Biotech companies are increasingly collaborating with academic institutions in the market to fast track the development of novel therapeutics.
Top Player’s Company Profiles in Stem Cell Therapy Market
- Mesoblast Limited (Australia)
- Athersys, Inc. (USA)
- Novartis AG (Switzerland)
- Osiris Therapeutics, Inc. (USA)
- StemCell Technologies Inc. (Canada)
- JCR Pharmaceuticals Co., Ltd. (Japan)
- Anterogen Co., Ltd. (South Korea)
- BrainStorm Cell Therapeutics Inc. (USA)
- Takeda Pharmaceutical Company Limited (Japan)
- Pharmicell Co., Ltd. (South Korea)
- Cellular Dynamics International, Inc. (USA)
- Vericel Corporation (USA)
- Holostem Terapie Avanzate S.r.l. (Italy)
- Gamida Cell Ltd. (Israel)
- BioTime, Inc. (USA)
Stem Cell Therapy Market Recent Developments
- In July 2023, Remestemcel-L from Mesoblast Limited (Australia) has successfully finished Phase III studies for the treatment of paediatric steroid-refractory acute graft-versus-host disease. Mesoblast’s positioning in the global stem cell therapy market is reinforced by results of this study which are promising especially considering that such outcomes are catalysts towards possible FDA approval.
- In May 2023, To enhance Athersys’s market share and worldwide presence, we will accelerate our regulatory approvals while making the therapy more accessible in Asia. The MultiStem treatment, that is meant to be used as a therapy for stroke, uses allogenic stem cells. Such improved availability will eventually lead to its increased use; thus, promoting its demand across Asia.
- In April 2023, The Swiss company Novartis AG has started a new research project aimed at developing CAR-T cell treatments for malignancies of the blood. In this effort, Novartis will grow their stem cell therapy R&D pipeline and use advanced technologies to improve treatment effectiveness, thereby reinforcing their position at the forefront of a rapidly changing stem cell industry.
Stem Cell Therapy Key Market Trends
- Drug Companies Seek Specialized Talent Amidst Innovation in Therapeutics: As pharmaceutical companies are working on more intricate therapeutic areas and innovative drug delivery systems; they are looking for personnel having experience in the development of new products than at any other time. Increasingly, firms are exporting to companies with a rich history in unique areas like biology and controlled release formulations.
- Crucial Role of Compliance in Outsourced Pharmaceutical Product Development: Everyone working in the pharmaceutical industry is required to abide strictly by these regulations due to their stringency. Corporations that outsource product development are working harder to uphold strict quality standards and abide by regulations to satisfy the demands of pharmaceutical corporations and regulatory agencies.
Stem Cell Therapy Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, there are fast developments in the global stem cell therapy market due to advances made in regenerative medicine and growing need for new treatments. Stem cells, being our own building blocks, are important in the differentiation of specialized cells hence possessing vast curative capabilities for a variety of illnesses.
New paths have been opened by the advent of induced pluripotent stem cells (iPSCs) due to great advancements in research leading to reduced clinical trials costs and improved regenerative medicine. Nevertheless, ethical issues relating to human embryonic stem cells and challenges in large scale production still limit their use. Despite these constraints, the market is still competitive with major players constantly innovating.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 12.11 Billion |
| Market size value in 2031 | USD 28.79 Billion |
| Growth Rate | 10.1% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Stem Cell Therapy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Stem Cell Therapy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Stem Cell Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Stem Cell Therapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Stem Cell Therapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Stem Cell Therapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
